OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
1
Result
Show all
Save search
Copy query
Show results for
Proteomics
(1)
Organisms
Schizophyllum commune H4-8
(1)
Mycobacterium tuberculosis SP7
(1)
Oryza sativa Japonica Group
(1)
Crotalus durissus terrificus
(1)
Eriocheir sinensis
(1)
Candidatus Endoriftia persephonae
(1)
Mycobacterium tuberculosis SP10
(1)
Mycobacterium tuberculosis SP13
(1)
Cotesia typhae
(1)
Mycobacterium tuberculosis SP22
(1)
Enterobacter ludwigii
(1)
Corynebacterium diphtheriae bv. mitis str. ISS 3319
(1)
Chlamydomonas reinhardtii
(1)
Lama
(1)
Pyricularia oryzae P131
(1)
Enterococcus mundtii CRL35
(1)
Pongo pygmaeus
(1)
Oncorhynchus tshawytscha
(1)
Pseudomonas canadensis
(1)
Strongylocentrotus purpuratus
(1)
Influenza A virus (A/California/04/2009(H1N1))
(1)
Salmonella enterica subsp. enterica serovar Typhimurium
(1)
Homo
(1)
Bradyrhizobium diazoefficiens
(1)
Streptococcus pyogenes STAB901
(1)
Pseudomonas aeruginosa PAO1H2O
(1)
Megoura viciae
(1)
Human alphaherpesvirus 1 strain 17
(1)
Quercus petraea
(1)
Canis lupus
(1)
Repository
pride
(1)
Tissue
Permanent cell line cell
(1)
Cell culture
(1)
Disease
Cervix carcinoma
(1)
Technology Type
Gel-based experiment
(1)
Mass Spectrometry
(1)
Publication Date
2022
(1)
Lab affiliation
Department of Chemistry, University of Oslo, Oslo, Norway
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
SILAC-based quantitative proteomics of cancer cells treated with the anti-tumor antibody 14F7
An investigation of the effect of humanized 14F7 on HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC) in combination with LC-MS and microscopy.
ORGANISM(S):
Homo sapiens (Human)
2022-08-08
|
PXD024320
|
Pride
Cancer
Neugc gm3
Silac
Anti-tumor antibody
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
